financetom
Business
financetom
/
Business
/
Liberty Broadband Q3 Earnings Down, Revenue Up
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Liberty Broadband Q3 Earnings Down, Revenue Up
Nov 9, 2024 12:08 PM

08:43 AM EST, 11/07/2024 (MT Newswires) -- Liberty Broadband ( LBRDA ) reported Q3 earnings Thursday of $0.99 per diluted share, down from $1.10 a year earlier.

Three analysts polled by Capital IQ expected $1.99.

Revenue for the quarter ended Sept. 30 was $262 million, up from $240 million a year earlier.

Three analysts surveyed by Capital IQ expected $245 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Treatment.com AI Enters Into New M&A Credit Facility
Treatment.com AI Enters Into New M&A Credit Facility
Feb 13, 2025
10:36 AM EST, 02/13/2025 (MT Newswires) -- Treatment.com AI ( TREIF ) on Thursday said it has entered into a M&A credit facility to fund transaction expenses and closing costs associated with acquisitions such as Rocket Doctor. A statement noted the credit facility is for up to $1.5 million at an annual interest rate of 12% and for a term...
Crocs Issues Upbeat Full-Year Earnings Outlook as Fourth-Quarter Results Top Estimates
Crocs Issues Upbeat Full-Year Earnings Outlook as Fourth-Quarter Results Top Estimates
Feb 13, 2025
10:35 AM EST, 02/13/2025 (MT Newswires) -- Crocs ( CROX ) issued an upbeat full-year earnings outlook on Thursday as the shoemaker reported better-than-expected fourth-quarter results. The company anticipates per-share adjusted earnings to be in a range of $12.70 to $13.15 for 2025 on annual revenue growth of about 2% to 2.5%. The current consensus on FactSet is for non-GAAP...
Conduit Pharmaceuticals, Charles River Laboratories Partner to Evaluate Potential Lupus Treatment
Conduit Pharmaceuticals, Charles River Laboratories Partner to Evaluate Potential Lupus Treatment
Feb 13, 2025
10:35 AM EST, 02/13/2025 (MT Newswires) -- Conduit Pharmaceuticals ( CDT ) said Thursday it partnered with Charles River Laboratories International ( CRL ) to evaluate its AZD1656 drug candidate and its derivatives in a preclinical model of systemic lupus erythematosus, as part of its strategy to develop potential immunotherapies for autoimmune disorders. Financial terms of the collaboration were not...
PPL Misses EPS Estimates, Raises 3-Year Infrastructure Investment Plan To $20 Billion
PPL Misses EPS Estimates, Raises 3-Year Infrastructure Investment Plan To $20 Billion
Feb 13, 2025
PPL Corporation shares are trading lower after the company reported fourth-quarter FY24 operating revenue growth of $2.211 billion. The company beat the consensus of $2.048 billion. Meanwhile, adjusted EPS was 34 cents and missed the consensus of 37 cents. Electricity sales rose by 1% year over year (Y/Y), with the PA Regulated segment up 1.4% Y/Y and the KY Regulated segment increased by 0.6% Y/Y. Operating income decreased to $377 million from $390 million in the prior year quarter. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved